Cargando…
TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner
Previous studies have revealed that TIPE1 serves as a tumor suppressor gene in several tumor types. However, we demonstrated that TIPE1 can promote cervical cancer proliferation by suppressing p53 activity. Here, we showed that TIPE1 inhibits cervical cancer cell apoptosis both in vivo and in vitro....
Autores principales: | Jiang, Jie, Gao, Li, Lan, Yongting, Wang, Yang, Zhao, Peiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843385/ https://www.ncbi.nlm.nih.gov/pubmed/33520705 http://dx.doi.org/10.3389/fonc.2020.593615 |
Ejemplares similares
-
FAM53A Affects Breast Cancer Cell Proliferation, Migration, and Invasion in a p53-Dependent Manner
por: Zhang, Jie, et al.
Publicado: (2019) -
SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
por: Lv, Hong-Wei, et al.
Publicado: (2021) -
Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway
por: Wang, Xi, et al.
Publicado: (2020) -
TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis
por: Wang, Xiao-Yu, et al.
Publicado: (2022) -
A Novel Prognostic Factor TIPE2 in Bladder Cancer
por: Jiang, Yu, et al.
Publicado: (2022)